AuroRNA Biotech Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
AuroRNA Biotech General Information
Description
Developer of mRNA technology. The company builds an independent and integrated mRNA platform to research, develop, and produce mRNA technology, providing innovative HPV-positive head and neck cancer products.
Contact Information
Corporate Office
- 3rd Floor, Building D-1, Building 16, Tree House
- No. 73 Tanmi Road, Jiangbei New District
- Nanjing, Jiangsu
- China
Corporate Office
- 3rd Floor, Building D-1, Building 16, Tree House
- No. 73 Tanmi Road, Jiangbei New District
- Nanjing, Jiangsu
- China
AuroRNA Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
AuroRNA Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
AuroRNA Biotech FAQs
-
When was AuroRNA Biotech founded?
AuroRNA Biotech was founded in 2020.
-
Where is AuroRNA Biotech headquartered?
AuroRNA Biotech is headquartered in Nanjing, China.
-
What industry is AuroRNA Biotech in?
AuroRNA Biotech’s primary industry is Biotechnology.
-
Is AuroRNA Biotech a private or public company?
AuroRNA Biotech is a Private company.
-
What is AuroRNA Biotech’s current revenue?
The current revenue for AuroRNA Biotech is .
-
Who are AuroRNA Biotech’s investors?
etherna and Grand Pharmaceutical have invested in AuroRNA Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process